IMO-T 2.13 CGI-T -0.07 AC-T -0.05 LNR-T 1.37 LLY-N 2.04 META-Q 0.82 NVDA-Q -0.21
Daily Stock Opinions and Ratings
Stockchase Opinions

Ed Ho Inex Pharmaceuticals Corp IEX-T BUY Mar 24, 2004

A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.
Ed HoEd Ho
Unknown
Unlock Rating
$7.430

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

TOP PICK

Inex Pharmaceuticals Corp(IEX-T)

Dec 05, 2001
A speculative choice, but has a good RISK/RETURN.
Martin Hubbes, CFAMartin Hubbes, CFA
Unknown
Unlock Rating
$7.550

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Inex Pharmaceuticals Corp(IEX-T)

Mar 06, 2002
(Was a top pick on Dec 5 no change) Still likes.
Martin Hubbes, CFAMartin Hubbes, CFA
Unknown
Unlock Rating
$7.150

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

Inex Pharmaceuticals Corp(IEX-T)

Mar 21, 2002
In phase 3 trials. Speculative.
Bruce CooperBruce Cooper
Unknown
Unlock Rating
$6.500

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Inex Pharmaceuticals Corp(IEX-T)

Dec 06, 2002
There will be some delay in their filings with FDA.
Glenn Paradis, BA, CFAGlenn Paradis, BA, CFA
Unknown
Unlock Rating
$4.900

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Inex Pharmaceuticals Corp(IEX-T)

Jan 16, 2003
Needs approval by FDA. Nice cash balance.
Mike WeirMike Weir
Unknown
Unlock Rating
$4.140

Stock price when the opinion was issued

biotechnology pharmaceutical
HOLD

Inex Pharmaceuticals Corp(IEX-T)

Feb 10, 2003
Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.
Mike WeirMike Weir
Unknown
Unlock Rating
$3.770

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Inex Pharmaceuticals Corp(IEX-T)

Apr 04, 2003
Need to get FDA approval. Too speculative for their funds.
David BaskinDavid Baskin
Unknown
Unlock Rating
$3.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Inex Pharmaceuticals Corp(IEX-T)

May 29, 2003
If you like biotechs, this could be OK. Speculative.
Andrew McCreathAndrew McCreath
Unknown
Unlock Rating
$4.550

Stock price when the opinion was issued

biotechnology pharmaceutical
COMMENT

Inex Pharmaceuticals Corp(IEX-T)

Apr 17, 2007
This is a penny stock and they tend to be promoted.
Kenneth P. Norquay, CMTKenneth P. Norquay, CMT
No
Unlock Rating
$1.100

Stock price when the opinion was issued

biotechnology pharmaceutical

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

HRTG-N -0.007$18.863
EIF-T 0.37$48.84
MRK-N 0.35$78.35
MDI-T -0.11$8.3
DBM-T 0.03$6.86
Advertising

Today's Top Picks

IMO-T 2.13$88.37
CGI-T -0.07$33
AC-T -0.05$13.97
LNR-T 1.37$48.15
LLY-N 2.04$842

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

RH-N 0.12$161.25
LVMUY-… 0$109.54
NXPI-Q 0.18$170.92
DAL-N 0.07$40.92
AMD-Q -0.03$87.47

Most Recent Experts

Bruce Murray

The Murray Wealth Group

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Stockchase Insights

5i Research

Advertising
Advertising
© Stockchase Inc.